Compugen (CGEN) SVP Levine Zurit Exercises Options, Sells Shares

What Happened
Levine Zurit, Senior Vice President, Business Development at Compugen Ltd. (CGEN), exercised options to acquire a total of 3,125 shares and sold 3,125 shares in the open market on April 10, 2026. The exercises were: 1,125 shares at $0.83 ($933) and 2,000 shares at $1.15 ($2,300), for a total cash cost of $3,233. The subsequent sale of 3,125 shares was executed at a weighted average price of $2.56, yielding $8,013. The filing also shows the derivative positions (the options) marked as disposed at $0, reflecting conversion/exercise of those options.

Key Details

• Transaction dates: April 10, 2026 (reported on Form 4 filed April 13, 2026).
• Exercises (M): 1,125 shares @ $0.83 = $933; 2,000 shares @ $1.15 = $2,300 (total acquired 3,125 shares for $3,233).
• Sale (S): 3,125 shares sold @ weighted avg $2.56 = $8,013 (prices ranged $2.50–$2.60; reporting person can provide per-share breakdown) (Footnote F2).
• Derivative disposition entries at $0 reflect conversion/exercise of the options (reported as disposed).
• Sale executed pursuant to a Rule 10b5-1 trading plan adopted Dec 23, 2025 (Footnote F1).
• Vesting notes: the two option grants have staged vesting schedules (Footnotes F3, F4).
• Shares owned after transaction: not stated in the provided excerpt of the filing.

Context

• This is an option exercise followed by an immediate open-market sale of the exercised shares (a common cashless exercise/monetization pattern).
• The sale was executed under a prearranged 10b5-1 plan, which typically pre-specifies timing/amounts and is often used to avoid questions about trading on material nonpublic information.
• Filing shows factual transaction details only; no inference about the Reporting Person’s view of the company should be assumed.